Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 770,647 |
|
|||||
| News | - | ||||||
| Day High | 4.76 | Low High |
|||||
| Day Low | 4.25 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sagiment Biosciences Inc | SGMT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.13 | -2.92% | 4.32 | 17:58:40 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.62 | 4.25 | 4.76 | 4.32 | 4.45 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,869 | 770,647 | US$ 4.46 | US$ 3,439,040 | - | 2.13 - 20.71 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:53:19 | 1 | US$ 4.62 | USD |
Sagiment Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 92.34M | 21.38M | - | 2M | -27.88M | -1.30 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sagiment Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SGMT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.00 | 4.95 | 3.88 | 4.22 | 567,162 | 0.32 | 8.00% |
| 1 Month | 5.39 | 5.56 | 3.83 | 4.48 | 418,455 | -1.07 | -19.85% |
| 3 Months | 6.05 | 8.75 | 3.83 | 5.65 | 860,880 | -1.73 | -28.60% |
| 6 Months | 3.84 | 20.71 | 2.13 | 10.32 | 998,197 | 0.48 | 12.50% |
| 1 Year | 15.50 | 20.71 | 2.13 | 10.41 | 663,889 | -11.18 | -72.13% |
| 3 Years | 15.50 | 20.71 | 2.13 | 10.41 | 663,889 | -11.18 | -72.13% |
| 5 Years | 15.50 | 20.71 | 2.13 | 10.41 | 663,889 | -11.18 | -72.13% |
Sagiment Biosciences Description
| Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California. |
